BREGNI, Giacomo et al. Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer. Acta Oncologica, [S. l.], v. 60, n. 4, p. 549–553, 2021. DOI: 10.1080/0284186X.2020.1871067. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/21484. Acesso em: 1 jun. 2026.